APA (7th ed.) Citation

Murphy, C. E., Lawther, A. J., Webster, M. J., Asai, M., Kondo, Y., Matsumoto, M., . . . Weickert, C. S. (2020). Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines. BMC.

Chicago Style (17th ed.) Citation

Murphy, Caitlin E., Adam J. Lawther, Maree J. Webster, Makoto Asai, Yuji Kondo, Mitsuyuki Matsumoto, Adam K. Walker, and Cynthia Shannon Weickert. Nuclear Factor Kappa B Activation Appears Weaker in Schizophrenia Patients with High Brain Cytokines than in Non-schizophrenic Controls with High Brain Cytokines. BMC, 2020.

MLA (9th ed.) Citation

Murphy, Caitlin E., et al. Nuclear Factor Kappa B Activation Appears Weaker in Schizophrenia Patients with High Brain Cytokines than in Non-schizophrenic Controls with High Brain Cytokines. BMC, 2020.